Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4246 AL 4260

Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer's Disease

Kamkwalala AR, Newhouse PA.

Curr Alzheimer Res. 2017;14(4):377-392. doi: 10.2174/1567205013666160930112625.

[Memantine as add-on medication to acetylcholinesterase inhibitor therapy for Alzheimer dementia]

Haussmann R, Donix M.

Nervenarzt. 2017 Jan;88(1):40-45. doi: 10.1007/s00115-016-0237-3.

Repetitive transcranial magnetic stimulation improves cognitive function of Alzheimer's disease patients

Zhao J, Li Z, Cong Y, Zhang J, Tan M, Zhang H, Geng N, Li M, Yu W, Shan P.

Oncotarget. 2017 May 16;8(20):33864-33871. doi: 10.18632/oncotarget.13060.

Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors

Lee SJ, Nam E, Lee HJ, Savelieff MG, Lim MH.

Chem Soc Rev. 2017 Jan 23;46(2):310-323. doi: 10.1039/c6cs00731g.

Alzheimer's disease and other dementias: update on research

Schneider L.

Lancet Neurol. 2017 Jan;16(1):4-5. doi: 10.1016/S1474-4422(16)30356-8.

Current opinion in Alzheimer's disease therapy by nanotechnology-based approaches

Ansari SA, Satar R, Perveen A, Ashraf GM.

Curr Opin Psychiatry. 2017 Mar;30(2):128-135. doi: 10.1097/YCO.0000000000000310.

The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial

Carotenuto A, Rea R, Traini E, Fasanaro AM, Ricci G, Manzo V, Amenta F.

J Alzheimers Dis. 2017;56(2):805-815. doi: 10.3233/JAD-160675.

Insulin Resistance in Alzheimer Disease: p53 and MicroRNAs as Important Players

Gasiorowski K, Brokos B, Leszek J, Tarasov VV, Ashraf GM, Aliev G.

Curr Top Med Chem. 2017;17(12):1429-1437. doi: 10.2174/1568026617666170103161233.

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease

Moussa C, Hebron M, Huang X, Ahn J, Rissman RA, Aisen PS, Turner RS.

J Neuroinflammation. 2017 Jan 3;14(1):1. doi: 10.1186/s12974-016-0779-0.

A Perspective on Crocus sativus L. (Saffron) Constituent Crocin: A Potent Water-Soluble Antioxidant and Potential Therapy for Alzheimer's Disease

Finley JW, Gao S.

J Agric Food Chem. 2017 Feb 8;65(5):1005-1020. doi: 10.1021/acs.jafc.6b04398. Epub 2017 Jan 31.

Solanezumab: too late in mild Alzheimer's disease?

The Lancet Neurology.

Lancet Neurol. 2017 Feb;16(2):97. doi: 10.1016/S1474-4422(16)30395-7.

Acute renal failure caused by cilostazol in a patient with Alzheimer's disease

Nomoto H, Matsubara Y, Ichimiya Y, Arai H.

Geriatr Gerontol Int. 2017 Jan;17(1):171-172. doi: 10.1111/ggi.12760.

Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled Trial

Decourt B, Drumm-Gurnee D, Wilson J, Jacobson S, Belden C, Sirrel S, Ahmadi M, Shill H, Powell J, Walker A, Gonzales A, Macias M, Sabbagh MN.

Curr Alzheimer Res. 2017;14(4):403-411. doi: 10.2174/1567205014666170117141330.

Targeting β-amyloid plaques and oligomers: development of near-IR fluorescence imaging probes

Liu H, Yang J, Wang L, Xu Y, Zhang S, Lv J, Ran C, Li Y.

Future Med Chem. 2017 Feb;9(2):179-198. doi: 10.4155/fmc-2016-0185. Epub 2017 Jan 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias